Gene silencing using a conjugate comprising Tat peptide and antisense oligonucleotide with phosphorothioate backbones

Bioorganic & Medicinal Chemistry Letters
Yoshiya MaegawaKazuo Sakurai

Abstract

Antisense oligonucleotides (ASOs) have a great therapeutic potential for the modulation of gene expression because of the high specificity. The major obstacles for clinical application are enzymatic degradation and low uptake into cells in vivo. In this study, we prepared the conjugate comprising Tat peptide and ASO with phosphorothioate linkages in a simple manner; azide alkyne Huisgen cycloaddition using a copper catalyst. The obtained conjugate showed a high stability in serum, compared with the conjugate with phosphodiester linkages. The conjugates with antisense for c-myb that is transcriptional factor concerning cell growth inhibited the cell proliferation in a dose dependent manner sequence-specifically. These findings suggest Tat-mediated ASOs delivery is useful for the treatment of various diseases.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·M L Stephenson, P C Zamecnik
Aug 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H J Ryser, W C Shen
Mar 1, 1990·Journal of Biochemical and Biophysical Methods·J M CampbellE Wickstrom
Jan 1, 1996·Critical Reviews in Oncogenesis·L Wolff
Mar 3, 1998·Biochemical and Biophysical Research Communications·L ChaloinF Heitz
Nov 2, 2002·The Journal of Biological Chemistry·Jean Philippe RichardBernard Lebleu
Feb 5, 2004·FEBS Letters·Aleksandra Muratovska, Michael R Eccles
Feb 13, 2004·The Journal of Biological Chemistry·Hongjiang WuStanley T Crooke
Jul 23, 2004·Current Molecular Medicine·Stanley T Crooke
Feb 3, 2005·The Journal of Biological Chemistry·Jean Philippe RichardLeonid V Chernomordik
Feb 22, 2005·Advanced Drug Delivery Reviews·Hilary BrooksEric Vivès
Jan 12, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Helerin MargusMargus Pooga

❮ Previous
Next ❯

Citations

Jan 5, 2018·Molecular Pharmaceutics·Kira AstakhovaKevin Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2022 Meta ULC. All rights reserved